113 related articles for article (PubMed ID: 8608568)
1. Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.
Itoh F; Yamamoto H; Hinoda Y; Imai K
Cancer; 1996 Apr; 77(8 Suppl):1717-21. PubMed ID: 8608568
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin.
Yamamoto H; Itoh F; Hinoda Y; Senota A; Yoshimoto M; Nakamura H; Imai K; Yachi A
Biochem Biophys Res Commun; 1994 Jun; 201(2):657-64. PubMed ID: 8002999
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of matrilysin antisense oligonucleotides on human colon cancer cell invasion in vitro.
Momiyama N; Koshikawa N; Ishikawa T; Ichikawa Y; Hasegawa S; Nagashima Y; Mitsuhashi M; Miyazaki K; Shimada H
Mol Carcinog; 1998 May; 22(1):57-63. PubMed ID: 9609101
[TBL] [Abstract][Full Text] [Related]
4. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.
Witty JP; McDonnell S; Newell KJ; Cannon P; Navre M; Tressler RJ; Matrisian LM
Cancer Res; 1994 Sep; 54(17):4805-12. PubMed ID: 8062282
[TBL] [Abstract][Full Text] [Related]
5. Matrix-degrading metalloproteinases in tumor progression.
Matrisian LM; Wright J; Newell K; Witty JP
Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
[TBL] [Abstract][Full Text] [Related]
6. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
[TBL] [Abstract][Full Text] [Related]
7. [Genetic diagnosis of colorectal cancer].
Itoh F; Imai K
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):9-14. PubMed ID: 8727369
[TBL] [Abstract][Full Text] [Related]
8. Modulation of matrix metalloproteinase-7 (matrilysin) secretion in coculture of human colon carcinoma cells with fibroblasts from orthotopic and ectopic organs.
Kataoka H; Meng JY; Uchino H; Nabeshima K; Kihira Y; Matuo Y; Koono M
Oncol Res; 1997; 9(3):101-9. PubMed ID: 9220495
[TBL] [Abstract][Full Text] [Related]
9. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
Yamamoto H; Iku S; Adachi Y; Imsumran A; Taniguchi H; Nosho K; Min Y; Horiuchi S; Yoshida M; Itoh F; Imai K
J Pathol; 2003 Feb; 199(2):176-84. PubMed ID: 12533830
[TBL] [Abstract][Full Text] [Related]
10. Suppression of matrilysin inhibits colon cancer cell invasion in vitro.
Yamamoto H; Itoh F; Hinoda Y; Imai K
Int J Cancer; 1995 Apr; 61(2):218-22. PubMed ID: 7705951
[TBL] [Abstract][Full Text] [Related]
11. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
Collins HM; Morris TM; Watson SA
Br J Cancer; 2001 Jun; 84(12):1664-70. PubMed ID: 11401321
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
Shattuck-Brandt RL; Lamps LW; Heppner Goss KJ; DuBois RN; Matrisian LM
Mol Carcinog; 1999 Mar; 24(3):177-87. PubMed ID: 10204802
[TBL] [Abstract][Full Text] [Related]
14. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
15. Nonpolarized secretion of human meprin alpha in colorectal cancer generates an increased proteolytic potential in the stroma.
Lottaz D; Maurer CA; Hahn D; Büchler MW; Sterchi EE
Cancer Res; 1999 Mar; 59(5):1127-33. PubMed ID: 10070973
[TBL] [Abstract][Full Text] [Related]
16. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
17. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice.
Powell WC; Knox JD; Navre M; Grogan TM; Kittelson J; Nagle RB; Bowden GT
Cancer Res; 1993 Jan; 53(2):417-22. PubMed ID: 8417833
[TBL] [Abstract][Full Text] [Related]
18. Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis.
Newell KJ; Matrisian LM; Driman DK
Mol Carcinog; 2002 Jun; 34(2):59-63. PubMed ID: 12112311
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
[TBL] [Abstract][Full Text] [Related]
20. Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.
Wang F; Reierstad S; Fishman DA
Cancer Lett; 2006 May; 236(2):292-301. PubMed ID: 16019136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]